DOI: 10.7504/nk2014050203
Clinical practice of antiviral treatment for liver cirrhosis patients with chronic hepatitis B
NIE Qing-He
Abstract：Researchers within China and worldwide have come to a consensus on antiviral treatment of iLiver cirrhosis with hepatitis B,which has been written in the domestic and foreign relevant guidelines.Clinicians have been paying attention to the antiviral treatment of liver cirrhosis,how to achieve the goal of treatment,and how to treat drug-induced side effects,etc.This paper mainly discusses the diagnosis and staging of liver cirrhosis,importance and goal of antiviral treatment,course of treatment,and clinical characteristics of five nucleoside analogues (acid),emphasizes that antiviral treatment can only slow progression in liver disease,but cannot change the results of end end-stage liver cirrhosis.The author considers that timely antiviral treatment is essential and anti-fibrosis treatment is necessary for liver cirrhosis with hepatitis B patients in clinical practice.Meanwhile,compliance should be introduced at the same time to patients,because compliance education is the key to achieve treatment goals.
Keywords：liver cirrhosischronic hepatitis Bantiviral treatmentnucleoside analogues
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)